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1) Why Collaborate? 
 
- It is estimated that over 13,000 people within Devon have a diagnosis of dementia, which is predicted to rise to over 23,00 by 2030. These rates are significantly highly 
than the regional average across the majority of the UK, highlighting the demand for neurodegenerative research within the region. (Prince et al, 2014) 
 
- It is a primary aim of the NIHR to increase the opportunities for patients and the public to participate in, and benefit from, research. Furthermore the Prime Ministers 
2012 Challenge on Dementia has given increased impetus to focus on dementia research.   
 
- However within regions of Devon there has been limited opportunity to participate in dementia research. This is reflected in parts of the UK,  often due to a lack of 
staffing and specific experience required to address the multidisciplinary methodologies of neurodegenerative studies.  
   
- Royal Devon and Exeter NHS Foundation Trust (RD&E) and Devon Partnership NHS Trust (DPT), individually did not have the breadth of clinical skills and cognitive 
rating experience to secure complex commercial dementia studies. Therefore developing a synergistic collaborative research relationship was identified as a priority 
to address this issue. The Devon Dementia Collaboration (DDC) was initially devised by senior clinicians in DPT and RD&E and advocated by Dr Ray Sheridan, NIHR 
Clinical Research Lead. 
 
2) Building the  
Devon  
       Dementia Collaboration  
 
  
Building and Delivering a Successful Dementia 
Research Portfolio through Collaboration 
 
3) Challenges and Solutions faced 
 
- -        Collaboration results in: 
- Easier, faster and more coherent access to services,  
- a greater effect on systems,  and increased creative problem solving  
- -         Clinical research collaboration results in: 
- Positive outcomes in recruiting & retaining participants/carers for studies. 
Indirect benefits to the growth and development of the research team 
(Bozeman and Boardman, 2014).  
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4) Progress to date  - Summary 
 
Research Work 
Since the implementation of DDC , the team has: 
 
• Secured both academic and commercial trials based upon mutual recruitment goals 
 and the enhanced skill set of the combined staff.  
• Set up a complex commercial study , the TOMMORROW study.  
Provided information t0  750+ people, screening 204, then recruiting 32 to the study to date.  
• Recruited for the IDEAL study since August 2014, starting our academic portfolio and 
meeting with patients and support groups across the community.  
• Developed and improved their clinical and rating experience.  
Through increased access to training opportunities and peer supervision 
•  Ensured increased access to facilities, such as the Clinical Research Facility. 
•  Made a deliberate effort to develop a balanced portfolio, including academic research. 
This will enable us to undertake future commercial studies that require complex 
psychological rating scales, such as the Clinical Dementia Rating scale and the Clinical Global 
Impression of Change.   
• Established a skilled team of clinicians  
• Significantly increased the number of Expressions of Interest  from commercial and 
academic studies with complex methodologies and in diverse fields of dementia. 
 
Promotion and Development 
  
 The DDC has already been well represented at a regional PPI event for people with Dementia. 
Research staff gave presentations and contributed to an expert panel for discussion on issues 
raised by patients and carers. 
 
A local workshop was also delivered by DDC staff which was well attended by trust leads 
throughout the peninsula, developing good practice.   
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Challenges 
 
 
 Allocation of 
recruitment accruals 
 
  
 
Financial 
arrangements  
 
 
 
 
 Integration of teams  
 
 
 
 
 Communication and 
coordination 
between sites  
 
 
 
 Inexperience in 
specific cognitive 
rating scales for 
commercial studies    
 
 
Solutions  
 
 Determine study 
specific agreements on 
recruitment  
 
  
Individual studies 
examined and 
arrangements agreed 
upon by team leads 
based on workload  
 
 Honorary contracts 
issued, regular team 
meetings and 
integration of IT 
systems  
 
Identification of study 
specific coordinator and 
agreed methods of 
communication.  
 
 
Shadowing, clinical and 
peer supervision. Focus 
on developing a 
balanced study 
portfolio.   
Outcomes 
 
 
Shift in focus from 
proving accruals to 
providing quality 
research. 
 
 Fair distribution of 
income  
 
 
 
 DDC team has now  
developed its own 
sense of unity and 
team cohesion. 
 
  
 Increased 
organisation and 
effective study 
planning and 
communication 
 
Increased skillset 
development in staff 
members  
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